STATE STREET CORP, a registered investment adviser, initiated a new position in Merck & Co., Inc. (NYSE:MRK) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 120,040,168 shares of the Healthcare company, valued at approximately $12.7B as of the filing date.
Merck & Co., Inc.'s stock currently trades at $122.26 with a market capitalization of $248.8B.
